Just when you thought men were destined to have all the drug-induced sexual mania via Cialis and Viagra for women, along comes promising research that seems to point toward an equivalent drug targeted toward women. Specifically, a new testosterone gel is being tested to treat "hypoactive sexual desire disorder," which apparently affects one-third of American women (!). As the article notes, "Testosterone plays a key role in sexual functioning for men and women," and a drop in testosterone in women (as a result of, for instance, an ovariectomy) can lead to a drop in sexual desire.
To the rescue, hopefully, will be LibiGel:
LibiGel comes in a pump bottle. The woman rubs the small dot of gel into the skin of her upper arm. Over the next 24 hours, the gel's testosterone seeps into her bloodstream, boosting her energy and libido.
Clayton, who is running the clinical trial at UVa, said the drug is better than previous testosterone treatments because it keeps levels of the chemical constant, much like naturally occurring testosterone.
"I expect this will work," she said.
In its second-phase clinical trials at 17 institutions, LibiGel led to a 283 percent increase of satisfying sexual encounters for the women taking the drug.
Hear hear! I am having a hard time imagining being on the receiving end of a 283 percent increase of satisfying sexual encounters, but that is undoubtedly because I am weak.